1. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (10th December 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 320 Phase IIa study of alpha-DC1 vaccine against HER2/HER3, chemokine modulation regimen and pembrolizumab in patients with asymptomatic brain metastasis from triple negative or HER2+ breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Forsyth, Peter; Opyrchal, Mateusz; Ahmed, Kamran; Khong, Hung; Attwood, Kristopher; Levine, Ellis; O'Connor, Tracey; Early, Amy; Fenstermaker, Robert; Prasad, Dheerendra; Takabe, Kazuaki; Czerniecki, Brian; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Opyrchal, Mateusz; Ford, Cayla; Fitzpatrick, Victoria; Grimm, Melissa; Basse, Per; Quinn, Marie; Witkiewicz, Agnieszka; Attwood, Kristopher; Ernstoff, Marc; O'Connor, Tracey; Early, Amy; Levine, Ellis; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020) Authors: Gandhi, Shipra; Opyrchal, Mateusz; Ford, Cayla; Fitzpatrick, Victoria; Grimm, Melissa; Basse, Per; Quinn, Marie; Witkiewicz, Agnieszka; Attwood, Kristopher; Ernstoff, Marc; O'Connor, Tracey; Early, Amy; Levine, Ellis; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver. (10th December 2020) Authors: Mukherjee, Sarbajit; Boland, Patrick; Gupta, Medhavi; Grimm, Melissa; Attwood, Kristopher; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 334 Phase II study evaluating a chemokine-modulatory (CKM) regimen in patients with colorectal cancer (CRC) metastatic to the liver. (9th November 2020) Authors: Mukherjee, Sarbajit; Boland, Patrick; Gupta, Medhavi; Grimm, Melissa; Attwood, Kristopher; Kalinski, Pawel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 46 Effectiveness of Palliative Hemostatic Radiotherapy for Hemoptysis; A Prospective Single Arm Observational Study. (October 2019) Authors: Busca, Ionut; Bhattacharya, Gaurav; Dennis, Kristopher; Attwood, Kristopher; Aljabab, Saif; MacRae, Robert Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. (16th April 2013) Authors: Haslinger, Michelle; Francescutti, Valerie; Attwood, Kristopher; McCart, Judith Andrea; Fakih, Marwan; Kane, John M.; Skitzki, Joseph J. Journal: Cancer medicine Issue: Volume 2:Number 3(2013:Jun.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A new diagnostic accuracy measure and cut-point selection criterion. (December 2017) Authors: Dong, Tuochuan; Attwood, Kristopher; Hutson, Alan; Liu, Song; Tian, Lili Journal: Statistical methods in medical research Issue: Volume 26:Number 6(2017) Page Start: 2832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A phase I study of the anaplastic lymphoma kinase inhibitor ceritinib in combination with gemcitabine‐based chemotherapy in patients with advanced solid tumors. Issue 12 (27th August 2021) Authors: Fountzilas, Christos; Adjei, Alex; Opyrchal, Mateusz; Evans, Rachel; Ghasemi, Mohammad; Attwood, Kristopher; Groman, Adrienne; Bshara, Wiam; Goey, Andrew; Wilton, John; Ma, Wen Wee; Iyer, Renuka Journal: International journal of cancer Issue: Volume 149:Issue 12(2021) Page Start: 2063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗